- Home
- BBIO vs BIDU Comparison
BBIO vs BIDU Comparison
Compare BBIO & BIDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBIO | BIDU |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 32.4B |
| IPO Year | 2019 | 2005 |
Fundamental Metrics
Financial Performance| Metric | BBIO | BIDU |
|---|---|---|
| Price | $69.20 | $92.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 25 | 13 |
| Target Price | $86.33 | ★ $154.38 |
| AVG Volume (30 Days) | 1.9M | ★ 2.2M |
| Earning Date | 05-12-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $502,076,000.00 | N/A |
| Revenue This Year | $89.45 | $5.11 |
| Revenue Next Year | $73.78 | $7.44 |
| P/E Ratio | ★ N/A | $42.45 |
| Revenue Growth | ★ 126.26 | N/A |
| 52 Week Low | $48.78 | $88.23 |
| 52 Week High | $93.42 | $165.30 |
Technical Indicators
Market Signals| Indicator | BBIO | BIDU |
|---|---|---|
| Relative Strength Index (RSI) | 23.26 | 44.42 |
| Support Level | $66.58 | $89.60 |
| Resistance Level | $70.49 | $99.64 |
| Average True Range (ATR) | 2.33 | 1.75 |
| MACD | -0.73 | 0.46 |
| Stochastic Oscillator | 9.34 | 38.48 |
Price Performance
Historical ComparisonAbout BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BIDU Baidu Inc. ADS
Most of Baidu's revenue comes from Baidu core, with the rest coming from video-streaming subsidiary iQiyi. The firm's main businesses include online marketing services from its search engine, AI cloud infrastructure, AI applications, AI marketing, and autonomous driving.